Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.32)
# 3,469
Out of 4,886 analysts
346
Total ratings
35.71%
Success rate
-14.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Reiterates: Buy | $75 | $35.87 | +109.09% | 38 | Jul 8, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $9.60 | +212.50% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $22.61 | +94.60% | 14 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $65 | $51.19 | +26.98% | 4 | Jun 27, 2025 | |
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $50 | $41.78 | +19.67% | 4 | Jun 26, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $17.32 | -42.26% | 14 | Jun 25, 2025 | |
| LYEL Lyell Immunopharma | Maintains: Neutral | $1 → $10 | $9.15 | +9.29% | 13 | Jun 24, 2025 | |
| VERV Verve Therapeutics | Downgrades: Neutral | $14 | $11.16 | +20.97% | 7 | Jun 18, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $30 | $10.25 | +192.68% | 4 | Jun 16, 2025 | |
| TIL Instil Bio | Reiterates: Buy | $125 | $23.64 | +428.76% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.75 | +215.79% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.09 | +358.72% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $54.22 | +32.79% | 36 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $2.54 | +96.85% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.37 | +110.97% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $4.54 | +230.40% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $19.50 | +130.77% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $100 | $12.58 | +694.91% | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $3.31 | +322.96% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.54 | +18.11% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $10.86 | +268.32% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.34 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.69 | +314.20% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.10 | +172.73% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.55 | +263.57% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.54 | +1,578.17% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.75 | +160.87% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $13.29 | +238.60% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.40 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.12 | +54,464,185.71% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.28 | - | 4 | Jun 2, 2023 |
Legend Biotech
Jul 8, 2025
Reiterates: Buy
Price Target: $75
Current: $35.87
Upside: +109.09%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $9.60
Upside: +212.50%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $22.61
Upside: +94.60%
CRISPR Therapeutics AG
Jun 27, 2025
Reiterates: Buy
Price Target: $65
Current: $51.19
Upside: +26.98%
Ionis Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $50
Current: $41.78
Upside: +19.67%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $17.32
Upside: -42.26%
Lyell Immunopharma
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $9.15
Upside: +9.29%
Verve Therapeutics
Jun 18, 2025
Downgrades: Neutral
Price Target: $14
Current: $11.16
Upside: +20.97%
Intellia Therapeutics
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $10.25
Upside: +192.68%
Instil Bio
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $23.64
Upside: +428.76%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $4.75
Upside: +215.79%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.09
Upside: +358.72%
May 29, 2025
Reiterates: Buy
Price Target: $72
Current: $54.22
Upside: +32.79%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $2.54
Upside: +96.85%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $2.37
Upside: +110.97%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $4.54
Upside: +230.40%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $19.50
Upside: +130.77%
May 8, 2025
Maintains: Buy
Price Target: $115 → $100
Current: $12.58
Upside: +694.91%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $3.31
Upside: +322.96%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.54
Upside: +18.11%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $10.86
Upside: +268.32%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.69
Upside: +314.20%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.10
Upside: +172.73%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.55
Upside: +263.57%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.54
Upside: +1,578.17%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.75
Upside: +160.87%
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $13.29
Upside: +238.60%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.40
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.12
Upside: +54,464,185.71%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.28
Upside: -